Literature DB >> 3345516

Involvement of soybean agglutinin binding cells in the lymphatic metastasis of the R3230AC rat mammary adenocarcinoma.

N D Buckley1, S A Carlsen.   

Abstract

Many human tumors, such as those of the breast, metastasize initially via the lymphatics. The tumor cell surface is believed to play a critical role in this process. To study the cell surface properties involved in dissemination, the poorly metastasizing R3230AC rat mammary adenocarcinoma was enriched for metastasizing cells by excising rare lymph node metastases arising after the s.c. injection of 10(6) cells and reinjecting these cells into another series of rats. By repeated enrichment cycles, the frequency of lymphatic metastasis was increased from 10 to 60-100% of the animals given injections. Fluorescein-conjugated lectins were used to probe the tumor cell surface. It was found that the percentage of cells in the population able to bind high levels of the lectin, soybean agglutinin (SBA), increased from 11 to almost 80% in the highly metastatic, enriched cell populations. A linear correlation (r = 0.92; P less than 0.001) was found between the percentage of cells in the population which bound high levels of SBA and the frequency of lymphatic metastasis in a series of enriched cell lines. Clones which bound high levels of SBA metastasized to lymph nodes at a high frequency, while clones which bound only low amounts of SBA exhibited a low frequency of lymphatic metastasis regardless of the metastatic potential of the cell line from which the clones were isolated. The binding of SBA to the cell was reduced by preincubation of the lectin with galactose, completely blocked by incubation with N-acetylgalactosamine, and unaffected by incubation with glucose or mannose, demonstrating that SBA was recognizing a N-acetylgalactosamine-containing component of the cell surface. Cells enriched for lymphatic metastasis were not similarly enriched for hematogenous metastasis. While cell lines enriched for lymphatic metastasis have been previously described, this is the first report of a specific cell surface property, SBA-binding, associated with lymphatic metastasis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3345516

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  11 in total

1.  Identification of differentially expressed genes in isogenic highly metastatic and poorly metastatic cell lines of R3230AC rat mammary adenocarcinoma.

Authors:  H Günes; S A Carlsen
Journal:  Cell Prolif       Date:  2003-12       Impact factor: 6.831

Review 2.  Adhesion mechanisms in lymphatic metastasis.

Authors:  P Brodt
Journal:  Cancer Metastasis Rev       Date:  1991-05       Impact factor: 9.264

3.  CREB3L1 is a metastasis suppressor that represses expression of genes regulating metastasis, invasion, and angiogenesis.

Authors:  Paul Mellor; Leah Deibert; Brian Calvert; Keith Bonham; Svein A Carlsen; Deborah H Anderson
Journal:  Mol Cell Biol       Date:  2013-10-14       Impact factor: 4.272

4.  The identification of a neutral glycosphingolipid antigenic marker for metastatic cells in the R3230AC rat mammary adenocarcinoma.

Authors:  S A Carlsen; M Barry; K Newton
Journal:  Clin Exp Metastasis       Date:  1990 Mar-Apr       Impact factor: 5.150

5.  Immunotherapy of the rat 13762SC mammary adenocarcinoma by vaccinia virus augmentation of tumor immunity.

Authors:  T P Archer; P Bretscher; B Ziola
Journal:  Clin Exp Metastasis       Date:  1990 Nov-Dec       Impact factor: 5.150

6.  Characterization of deoxyguanosine-resistant hypoxanthine-guanine phosphoribosyltransferase(-)metastatic variants altered in soybean-agglutinin-binding properties and cell-surface glycoproteins.

Authors:  J E Damen; M A Spearman; A H Greenberg; J A Wright
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

7.  Tumor cell adhesion to frozen lymph node sections--a correlate of lymphatic metastasis in breast carcinoma models of human and rat origin.

Authors:  P Brodt; L Fallavollita; R J Sawka; P Shibata; J Nip; U Kim; H Shibata
Journal:  Breast Cancer Res Treat       Date:  1990-12       Impact factor: 4.872

Review 8.  Tumor progression: potential role of unstable genomic changes.

Authors:  R P Hill
Journal:  Cancer Metastasis Rev       Date:  1990-09       Impact factor: 9.264

9.  Sequential alteration of peanut agglutinin binding-glycoprotein expression during progression of murine mammary neoplasia.

Authors:  J W Rak; D McEachern; F R Miller
Journal:  Br J Cancer       Date:  1992-05       Impact factor: 7.640

10.  Helix pomatia agglutinin binding in human tumour cell lines: correlation with pulmonary metastases in nude mice.

Authors:  I Kjønniksen; P D Rye; O Fodstad
Journal:  Br J Cancer       Date:  1994-06       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.